期刊
CELLULAR SIGNALLING
卷 24, 期 3, 页码 596-605出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2011.11.008
关键词
Peroxisome proliferator-activated receptor-gamma; Liver fibrosis; Hepatic stellate cell; Signal transduction; Cross-regulation
类别
资金
- National Natural Science Foundation of China [30873424]
- Jiangsu Natural Science Foundation [BK2008456]
- Project for Supporting Jiangsu Provincial Talents in Six Fields [2009-B-010]
- Doctoral Discipline Foundation of Ministry of Education of China [20103237110010]
- Jiangsu Key Laboratory of Acupuncture Medicine [KJA200801]
- Priority Academic Program Development of Jiangsu Higher Education Institutions [ysxk-2010]
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a nuclear receptor with transcriptional activity controlling multiple physical and pathological processes. Recently, PPAR gamma has been implicated in the pathogenesis of liver fibrosis. Its depleted expression has strong associations with the activation and transdifferentiation of hepatic stellate cells, the central event in liver fibrogenesis. Studies over the past decade demonstrate that PPAR gamma cross-regulates a number of signaling pathways mediated by growth factors and adipokines, and cellular events including apoptosis and senescence. These signaling and cellular events and their molecular interactions with PPAR-gamma system are profoundly involved in liver fibrogenesis. We critically summarize these mechanistic insights into the PPAR-gamma regulation in liver fibrogenesis based on the updated findings in this area. We conclude with a discussion of the impacts of these discoveries on the interpretation of liver fibrogenesis and their potential therapeutic implications. PPAR gamma activation could be a promising strategy for antifibrotic therapy. (C) 2011 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据